BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37339943)

  • 1. ELK1/KIFC1 axis promotes breast cancer cell proliferation by regulating glutathione metabolism.
    Yang B; Wang H; Xiao J; Chen W; Chen W
    J Obstet Gynaecol Res; 2023 Aug; 49(8):2175-2184. PubMed ID: 37339943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELK1-induced up-regulation of KIF26B promotes cell cycle progression in breast cancer.
    Wang S; Zhang H; Liu H; Guo X; Ma R; Zhu W; Gao P
    Med Oncol; 2021 Nov; 39(1):15. PubMed ID: 34817735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPX4 suppresses ferroptosis to promote malignant progression of endometrial carcinoma via transcriptional activation by ELK1.
    Wei S; Yu Z; Shi R; An L; Zhang Q; Zhang Q; Zhang T; Zhang J; Wang H
    BMC Cancer; 2022 Aug; 22(1):881. PubMed ID: 35962333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockdown of lncRNA LINC00662 suppresses malignant behaviour of osteosarcoma cells via competition with miR-30b-3p to regulate ELK1 expression.
    Wang B; Xu Z; Wang X; Xia S; Cai P; Wang M; Gao Z
    J Orthop Surg Res; 2022 Feb; 17(1):74. PubMed ID: 35123530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-suppressive miRNA-135a inhibits breast cancer cell proliferation by targeting ELK1 and ELK3 oncogenes.
    Ahmad A; Zhang W; Wu M; Tan S; Zhu T
    Genes Genomics; 2018 Mar; 40(3):243-251. PubMed ID: 29892795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated microRNA-130b-5p or silenced ELK1 inhibits self-renewal ability, proliferation, migration, and invasion abilities, and promotes apoptosis of cervical cancer stem cells.
    Huang Y; Luo F
    IUBMB Life; 2021 Jan; 73(1):118-129. PubMed ID: 33295145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA TDRG1 functions as an oncogene in cervical cancer through sponging miR-330-5p to modulate ELK1 expression.
    Zhao H; Hu GM; Wang WL; Wang ZH; Fang Y; Liu YL
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7295-7306. PubMed ID: 31539116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELK1‑mediated upregulation of lncRNA LBX2‑AS1 facilitates cell proliferation and invasion via regulating miR‑491‑5p/S100A11 axis in colorectal cancer.
    Ma G; Dai W; Zhang J; Li Q; Gu B; Song Y; Yang X
    Int J Mol Med; 2021 Jul; 48(1):. PubMed ID: 34080639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXC1 promotes HCC proliferation and metastasis by Upregulating DNMT3B to induce DNA Hypermethylation of CTH promoter.
    Lin Z; Huang W; He Q; Li D; Wang Z; Feng Y; Liu D; Zhang T; Wang Y; Xie M; Ji X; Sun M; Tian D; Xia L
    J Exp Clin Cancer Res; 2021 Feb; 40(1):50. PubMed ID: 33522955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXXC finger protein 4 inhibits the CDK18-ERK1/2 axis to suppress the immune escape of gastric cancer cells with involvement of ELK1/MIR100HG pathway.
    Li P; Ge D; Li P; Hu F; Chu J; Chen X; Song W; Wang A; Tian G; Gu X
    J Cell Mol Med; 2020 Sep; 24(17):10151-10165. PubMed ID: 32715641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinesin Family Member C1 (KIFC1) Regulated by Centrosome Protein E (CENPE) Promotes Proliferation, Migration, and Epithelial-Mesenchymal Transition of Ovarian Cancer.
    Li J; Diao H; Guan X; Tian X
    Med Sci Monit; 2020 Dec; 26():e927869. PubMed ID: 33361741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-597-5p inhibits cell growth and promotes cell apoptosis by targeting ELK1 in pancreatic cancer.
    Li S; Li X; Xing X; Wang L
    Hum Cell; 2020 Oct; 33(4):1165-1175. PubMed ID: 32613573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-185-5p suppresses HBV gene expression by targeting ELK1 in hepatoma carcinoma cells.
    Fan HX; Feng YJ; Zhao XP; He YZ; Tang H
    Life Sci; 2018 Nov; 213():9-17. PubMed ID: 30308183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.
    Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D
    J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid Zinc Finger 1 (MZF1) Maintains the Mesenchymal Phenotype by Down-regulating IGF1R/p38 MAPK/ERα Signaling Pathway in High-level MZF1-expressing TNBC cells.
    Yue CH; Liu JY; Chi CS; Hu CW; Tan KT; Huang FM; Pan YR; Lin KI; Lee CJ
    Anticancer Res; 2019 Aug; 39(8):4149-4164. PubMed ID: 31366500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ELK1 is up-regulated by androgen in bladder cancer cells and promotes tumor progression.
    Kawahara T; Shareef HK; Aljarah AK; Ide H; Li Y; Kashiwagi E; Netto GJ; Zheng Y; Miyamoto H
    Oncotarget; 2015 Oct; 6(30):29860-76. PubMed ID: 26342199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DDX6/KIFC1 signaling axis, as regulated by YY1, contributes to the malignant behavior of pancreatic cancer.
    Deng X; Liu Z; Wang B; Ma J; Meng X
    FASEB J; 2024 Apr; 38(7):e23581. PubMed ID: 38551642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional activation of miR-320a by ATF2, ELK1 and YY1 induces cancer cell apoptosis under ionizing radiation conditions.
    Hu Z; Tie Y; Lv G; Zhu J; Fu H; Zheng X
    Int J Oncol; 2018 Oct; 53(4):1691-1702. PubMed ID: 30066913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elemene induces cell apoptosis via inhibiting glutathione synthesis in lung adenocarcinoma.
    Song GQ; Wu P; Dong XM; Cheng LH; Lu HQ; Lin YY; Tang WY; Xie T; Zhou JL
    J Ethnopharmacol; 2023 Jul; 311():116409. PubMed ID: 37003401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis.
    Wu X; Kong C; Wu Y
    Bioengineered; 2021 Dec; 12(1):9046-9057. PubMed ID: 34657558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.